IMMIX BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.98 USD | -7.04% |
|
-2.94% | -71.39% |
Chart calendar Immix Biopharma, Inc.
6c6dcf7f2cf066df.D8xoE7_-ntW0CUHajuWaimKPQ3RVHnhteIzdaID_a8k.Q_gMTPqs0pnlZxKUy4rv0CvcAAcbdww_As2UAbLIAIxHijcq1YvwlN9RFA~b55e67752b655bf8b647ee3d18f5f6e7
Upcoming events on Immix Biopharma, Inc.
No events available
Past events on Immix Biopharma, Inc.
| 2024-06-11 12:00 | Annual General Meeting |
| 2024-05-10 08:45 | American Society of Gene & Cell Therapy Meeting - HBI0101 |
| 2023-12-11 21:00 | American Society of Hematology Meeting - Publication Number #4852 |
| 2023-12-10 15:45 | American Society of Hematology Meeting - Publication No - #538 |
| 2023-12-05 15:30 | JMP Securities Hematology And Oncology Summit |
| 2023-11-29 16:15 | Investor Meeting - Key Opinion Leaders |
| 2023-10-25 | Trailblazers Private Company Healthcare Conference |
| 2023-09-28 03:00 | International Myeloma Society Meeting |
| 2023-09-27 02:00 | International Myeloma Society Meeting |
| 2023-09-12 00:00 | H.C. Wainwright Global Investment Conference |
| 2023-06-06 | Annual General Meeting |
| 2023-05-19 12:15 | American Society of Gene & Cell Therapy Meeting - Oral Presentation |
| 2023-05-19 08:00 | American Society of Gene Cell Therapy Meeting - Late-Breaking Abstracts 1 |
| 2023-05-15 | American Society of Gene Cell Therapy Meeting |
| 2023-04-22 | European Society for Blood and Marrow Transplantation Meeting |
| 2023-03-14 13:30 | Roth Conference |
| 2023-02-08 | European Hematology Association CAR T-cell Meeting |
| 2022-10-26 14:00 | ThinkEquity Conference |
| 2022-04-05 09:30 | Investor Day |
| 2022-02-01 09:30 | Investor Day |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -8,22 -6,21 -32.42% | -16,1 -14,4 -12.38% | -22,0 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -8,22 -6,65 -23.66% | -16,1 -14,9 -8.64% | -22,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -8,22 -6,87 -19.67% | -15,6 -14,5 -7.48% | -21,4 |
|
Net income Million USD | Released Forecast Spread | -24,4 | -8,23 -6,87 -19.74% | -15,4 -14,5 -6.32% | -21,5 |
|
EPS USD | Released Forecast Spread | -6,64 | -0,59 -0,50 -18.79% | -0,89 -0,85 -4.71% | -0,93 |
| Announcement Date | 28/03/22 | 27/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |
|
EBIT Million USD | Released Forecast Spread | -3,79 -3,11 -22.01% | -2,52 -1,96 -28.48% | -3,72 -2,60 -43.16% | -4,52 -3,78 -19.68% | -5,38 -4,59 -17.12% | -5,59 -4,68 -19.47% | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,79 -3,11 -22.01% | -2,49 -1,96 -27.06% | -3,59 -2,60 -38.2% | -4,34 -3,78 -14.74% | -5,15 -4,59 -12.14% | -5,32 -4,68 -13.75% | |
|
Net income Million USD | Released Forecast Spread | -1,54 | -3,80 -3,11 -22.1% | -2,48 -1,97 -26% | -3,58 -2,60 -37.34% | -4,28 -3,79 -13.07% | -5,09 -4,60 -10.71% | -5,26 -4,69 -12.25% |
|
EPS USD | Released Forecast Spread | -0,11 | -0,27 -0,22 -22.73% | -0,18 -0,14 -28.57% | -0,24 -0,17 -41.18% | -0,23 -0,23 0% | -0,24 -0,23 -4.35% | -0,22 -0,23 4.35% |
| Announcement Date | 09/11/22 | 27/03/23 | 12/05/23 | 11/08/23 | 13/11/23 | 29/03/24 | 09/05/24 |
| 2024-07-11 02:00 | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 2024-07-15 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 2024-07-22 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 02:00 | BIOGAIA AB: Q2 2024 Earnings Release |
| 2024-07-23 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
| 2024-07-25 01:00 | UCB: Q2 2024 Earnings Release |
| 2024-07-25 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Immix Biopharma, Inc.
| 2024-05-23 05:43 | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 11:35 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 2024-05-13 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
| 2024-05-09 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-09 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 02:30 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-08 | HUGEL, INC.: Q1 2024 Earnings Release |
| 2024-05-08 16:16 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMMX Stock
- Calendar Immix Biopharma, Inc.
